JAMONY
NBSE
Jacob Asset Management of New York’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $13.6K | Hold |
15,655
| – | – | 0.02% | 66 |
|
|
2023
Q2 | $29K | Sell |
15,655
-297,445
| -95% | -$550K | 0.03% | 66 |
|
|
2023
Q1 | $57.9K | Hold |
313,100
| – | – | 0.07% | 63 |
|
|
2022
Q4 | $59.6K | Sell |
313,100
-157,424
| -33% | -$29.9K | 0.07% | 66 |
|
|
2022
Q3 | $186K | Hold |
470,524
| – | – | 0.2% | 59 |
|
|
2022
Q2 | $494K | Buy |
470,524
+44,100
| +10% | +$46.3K | 0.5% | 44 |
|
|
2022
Q1 | $802K | Hold |
426,424
| – | – | 0.49% | 42 |
|
|
2021
Q4 | $1.2M | Buy |
426,424
+18,924
| +5% | +$53.2K | 0.53% | 44 |
|
|
2021
Q3 | $1.47M | Buy |
407,500
+62,000
| +18% | +$224K | 0.53% | 46 |
|
|
2021
Q2 | $1.66M | Buy |
345,500
+110,000
| +47% | +$527K | 0.55% | 48 |
|
|
2021
Q1 | $1.74M | Buy |
235,500
+132,000
| +128% | +$975K | 0.67% | 41 |
|
|
2020
Q4 | $723K | Buy |
+103,500
| New | +$723K | 0.55% | 41 |
|